Litigation Details for Nuance Communications Inc. v. Omilia Natural Language Solutions, Ltd. (D. Mass. 2019)
✉ Email this page to a colleague
Nuance Communications Inc. v. Omilia Natural Language Solutions, Ltd. (D. Mass. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-06-28 |
| Court | District Court, D. Massachusetts | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Patti B. Saris |
| Jury Demand | Both | Referred To | |
| Parties | NUANCE COMMUNICATIONS INC.; OMILIA NATURAL LANGUAGE SOLUTIONS, LTD. | ||
| Patents | 10,080,733; 10,265,404; 10,508,307; 10,592,168; 8,133,699; 8,227,420; 8,623,834; 8,772,508; 9,090,558; 9,308,276; 9,382,321; 9,404,915; 9,555,112; 9,901,585 | ||
| Attorneys | Carrie Richey; Christian E. Mammen; Christine Dupriest; David Greenbaum; David R. Boaz; Hallie Kiernan; Jennifer Itzkoff; Kevin C. Adam; Kristin Lamb; Raj Gandesha | ||
| Firms | Nuance Communications, Inc.; White & Case LLP; White & Case, LLP; Womble Bond Dickinson (US) LLP; Womble Bond Dickinson LLP; Womble Bond Dickinson US LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Nuance Communications Inc. v. Omilia Natural Language Solutions, Ltd.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in Nuance Communications Inc. v. Omilia Natural Language Solutions, Ltd.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Nuance Communications Inc. v. Omilia Natural Language Solutions, Ltd. (D. Mass. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-05-06 | 92 | Memorandum & Order | Document 92 Filed 05/06/20 Page 10 of 24 accumulation of patents, no matter how many, is not in and…immunity in enforcing its patent if it obtained that patent through a fraud on the Patent Office, or if its…2014) (quoting Woods v. Wells Fargo Bank, N.A., 733 F.3d 349, 353 (1st Cir. 2013)). In addition…asserting baseless patent infringement litigation using its massive portfolio of acquired patents to drive its…Omilia’s systems infringe three patents owned by Nuance. Two of those patents are at issue in Nuance’s infringement | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
